General Information of Drug (ID: DM65XZJ)

Drug Name
5-deoxy-5-phosphono-D-arabinonate Drug Info
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
56603745
TTD Drug ID
DM65XZJ

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
GHRP-2 DMKGH0R Growth hormone deficiency 5A61.3 Approved [2]
Pyrophosphate 2- DMZQ75M Discovery agent N.A. Investigative [3]
4-phospho-D-erythronate DMW4KXQ Discovery agent N.A. Investigative [4]
6-Phosphogluconic Acid DMB1QCY Discovery agent N.A. Investigative [5]
(2R)-2-Methyl-4,5-dideoxy DM3K2TI Discovery agent N.A. Investigative [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Phosphogluconate dehydrogenase (PGD) TTZ3IFB 6PGD_HUMAN Inhibitor [1]

References

1 Sugar derivatives as new 6-phosphogluconate dehydrogenase inhibitors selective for the parasite Trypanosoma brucei. Bioorg Med Chem. 2003 Apr 3;11(7):1207-14.
2 Synthesis and biological evaluation of substrate-based inhibitors of 6-phosphogluconate dehydrogenase as potential drugs against African trypanosomiasis. Bioorg Med Chem. 2003 Jul 17;11(14):3205-14.
3 The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
4 Virtual fragment screening for novel inhibitors of 6-phosphogluconate dehydrogenase. Bioorg Med Chem. 2010 Jul 15;18(14):5056-62.
5 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.